The Roles of Nanoparticles in Ovarian Cancer Treatment and Diagnosis

Author:

Gogoi Bitupon1,Jain Devendra2,Sharma Madan Mohan1,Mishra Rajeev3,Singh Abhijeet1

Affiliation:

1. Manipal University Jaipur,Department of Biosciences,Jaipur,India,303007,

2. Maharana Pratap University of Agriculture and Technology,Department of Molecular Biology and Biotechnology,Udaipur,India,313001,

3. Chhatrapati Shahu Ji Maharaj University,Department of Life Science,Kanpur,India,208024,

Abstract

Ovarian cancer, an aggressive epithelial cancer, remains a major cause of cancer mortality worldwide among women, but it can be diagnosed at an early stage also. Surgical removal of ovarian tumour is a good option for the initial treatment, but this is suitable only at the early stage of cancer. Surgery and other therapies like chemotherapy, hormone role therapy and immunotherapy alone are insufficient for the treatment of today’s advanced ovarian cancer. The aim of this book chapter is to review the use of nano-particles in the treatment of ovarian cancer, along with surgery. It is believed that nano therapies have lots of advantages like they stabilize drugs in our body, deliver and penetrate the drugs to tumour-specific cells and can profile the toxicity of chemotherapy. This book chapter also covers the development of nanotherapies, types of nanocarriers and their role in ovarian cancer diagnosis and treatment<br>

Publisher

BENTHAM SCIENCE PUBLISHERS

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3